Companies: 10,795·Total market cap: $144.5T

Miromatrix Medical Inc.

Miromatrix Medical Inc.

MIRONASDAQHealthcare

$3.39

+$0.02(+0.59%)

Market Cap$92951088

P/E Ratio—

52W High$4.35

52W Low$0.906

Avg Volume190K

Open$3.38

Beta0.01

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Miromatrix Medical Inc.（MIRO）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · MIRO · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.13Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)958029.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding20.7MShares outstanding history

Next EarningsTBAEarnings history

探索 Miromatrix Medical Inc. 数据

分析师预测$9 · Buy

股息不分红

营收$953470+2783.54%

盈利EPS $-1.45-98.63%

财务快照

FY 2022Revenue$953470.00▲ +2783.54% YoY

202020212022

FY 2022Net Income-$30.0M▼ 100.64% YoY

202020212022

FY 2022EPS$-1.45▼ 98.63% YoY

202020212022

TTM:Revenue: $958029.00Net Income: -$27.1MEPS: $-1.13View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$9.00Low

$3.39Current

$9.00Avg Target上涨空间 165.49%

$9.00High

合计: 2 · 买入占比: 100.0%

根据过去 3 个月内 2 位华尔街分析师，MIRO 共识评级为 Buy，12 个月平均目标价 $9.00 （较现价 $3.39 上涨空间 165.49%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Miromatrix Medical Inc.

$3.39+0.59%$93.0M #2

Aadi Bioscience, Inc.

$2.05-2.38%$94.9M #3

Berkeley Lights, Inc.

$1.20-5.88%$86.6M #4

Cyteir Therapeutics, Inc.

$3.02-2.27%$108.7M #5

$2.09-0.48%$104.8M #6

IGM Biosciences, Inc.

$1.27+0.00%$77.5M

股票表现

1D+0.00%

1W+0.00%

1M+0.59%

3M+175.61%

YTD+0.00%

1Y+5.33%

5Y-77.76%

关于 Miromatrix Medical Inc.

CEOJeffrey James Ross

IPO DateJun 24, 2021

Employees76

CountryUS

Websitemiromatrix.com

Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary p…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Miromatrix Medical Inc.（MIRO）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 24, 2021 在 NASDAQ 上市。截至最近交易日，MIRO 股价为 $3.39，市值约为 $93.0M。过去12个月累计回报 +5.33%，年初至今回报 +0.00%。

根据 2 位华尔街分析师，Miromatrix Medical Inc. 股票共识评级为Buy，12个月平均目标价为 $9.00。2022 财年 Miromatrix Medical Inc. 营收 $953470.00，净利润 -$30.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Miromatrix Medical Inc.（MIRO）股价为 $3.39，在 NASDAQ 上市，52周区间为 $0.91 – $4.35。

MIRO 最新股价MIRO quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议